FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals Blisovi Fe 1 Recall

Blisovi Fe 1

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class II
Reported by FDA
Jan 15, 2020
Recall ID
D-0638-2020
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Blisovi Fe 1 starting Dec 26, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0638-2020 on Jan 15, 2020. Reason: Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.

Product description

Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11

Lot numbers, UPCs & expiration codes

Lot: H801227, Exp. Date January 2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0638-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 26, 2019
FDA report date
Jan 15, 2020
Quantity
41,863 cartons/3 wallets per carton
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0638-2020, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
84571
Address
Harborplace Tower
Address (line 2)
111 S Calvert St Fl 21st
Code information
Lot: H801227, Exp. Date January 2020
Postal code
21202-6174
Report date
Jan 15, 2020
Product type
Drugs
Recall number
D-0638-2020
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
41,863 cartons/3 wallets per carton
Termination date
Oct 22, 2020
Reason for recall
Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11
Distribution pattern
Nationwide within the United States
Recall initiation date
Dec 26, 2019
Initial firm notification
Letter
Center classification date
Jan 3, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0638-2020, published Jan 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls